(Q37052769)

English

Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder

scientific article published on August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

0 references

0 references

author name string

Walter Deberdt

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ilya Lipkovich

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Alexandra N Heinloth

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Lin Liu

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sara Kollack-Walker

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sara E Edwards

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Vicki Poole Hoffmann

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Thomas A Hardy

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 August 2008

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Therapeutics and Clinical Risk Management

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

713-720

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

1 August 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

4 September 2018

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical antipsychotic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

Compliance with medication regimens for mental and physical disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

29 September 2017

Effect on lipid profiles of switching from olanzapine to another second-generation antipsychotic agent in veterans with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

4 September 2018

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

4 September 2018

Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

4 September 2018

Amantadine for weight gain associated with olanzapine treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

4 September 2018

Weight decline in patients switching from olanzapine to quetiapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2621385

4 September 2018

Improvement in antipsychotic-related metabolic disturbances in patients with schizophrenia switched to ziprasidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19209252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19209252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness of switching antipsychotic medications

1 reference

https://pubmed.ncbi.nlm.nih.gov/19209252

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2147/TCRM.S3153

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37052769&oldid=2120222072"